elkedonia

Elkedonia is developing a neuroplastogen with novel target and mechanism of action, able to induce neuroplasticity without the side effects of psychedelics or of classical antidepressants. Acting fast, without inducing sedation, dependence or psychotic side effects: this is our ambition, based on our research data. Elkedonia is focusing on an innovative target, within neurons, in key brain circuits. Rather than acting at the synapse, Elkedonias approach targets intracellular events and neuroplasticity, acting precisely on a highly selective signaling pathway.